4.6 Review

Endosomal v-ATPase as a Sensor Determining Myocardial Substrate Preference

期刊

METABOLITES
卷 12, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/metabo12070579

关键词

heart; vacuolar-type H+-ATPase; endosomal acidification; lipid; glucose; amino acids; CD36; GLUT4

资金

  1. National Natural Science Foundation of China [8210033375]
  2. Dutch Heart Foundation Dekker grant [2019T041]
  3. ZonMw Off Road grant [04510011910065]

向作者/读者索取更多资源

The heart can utilize a variety of substrates for energy provision, with balanced substrate preference being crucial for cardiac function. Imbalance or chronic shift towards a single type of energy substrate is linked with cardiac dysfunction.
The heart is a metabolically flexible omnivore that can utilize a variety of substrates for energy provision. To fulfill cardiac energy requirements, the healthy adult heart mainly uses long-chain fatty acids and glucose in a balanced manner, but when exposed to physiological or pathological stimuli, it can switch its substrate preference to alternative substrates such as amino acids (AAs) and ketone bodies. Using the failing heart as an example, upon stress, the fatty acid/glucose substrate balance is upset, resulting in an over-reliance on either fatty acids or glucose. A chronic fuel shift towards a single type of substrate is linked with cardiac dysfunction. Re-balancing myocardial substrate preference is suggested as an effective strategy to rescue the failing heart. In the last decade, we revealed that vacuolar-type H+-ATPase (v-ATPase) functions as a key regulator of myocardial substrate preference and, therefore, as a novel potential treatment approach for the failing heart. Fatty acids, glucose, and AAs selectively influence the assembly state of v-ATPase resulting in modulation of its proton-pumping activity. In this review, we summarize these novel insights on v-ATPase as an integrator of nutritional information. We also describe its exploitation as a therapeutic target with focus on supplementation of AA as a nutraceutical approach to fight lipid-induced insulin resistance and contractile dysfunction of the heart.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据